Pathogenesis of MAFLD
MAFLD pathogenesis is fundamentally driven by systemic insulin resistance and metabolic dysregulation, leading to a cascade of hepatic lipid accumulation, lipotoxicity, mitochondrial dysfunction, oxidative stress, inflammatory activation, and progressive fibrosis through complex interorgan communication networks.
Core Metabolic Mechanisms
The disease begins with disruption of hepatic lipid metabolic homeostasis, which represents the central initiating event 1. This occurs through:
- Insulin resistance as the primary systemic driver, causing excessive hepatic lipid accumulation beyond simple steatosis 2, 3
- Dysregulated lipid metabolism with aberrant accumulation of specific lipotoxic lipid species within hepatocytes 1
- Mitochondrial dysfunction leading to impaired fatty acid oxidation and energy metabolism 2, 3
Cellular Stress and Inflammatory Pathways
Once lipid accumulation occurs, multiple pathological cascades activate:
- Oxidative stress from overwhelmed mitochondrial capacity 2, 3
- Lipotoxicity triggering cellular stress responses and hepatocyte injury 1, 3
- Inflammatory signaling including the cGAS/STING/NF-κB pathway, which forms a critical "DNA stress-inflammation-metabolic abnormality" chain 4
- Regulated cell death processes including apoptosis and other forms of programmed cell death 2
Interorgan Communication Networks
The gut-liver axis plays a critical mediating role in disease progression 5:
- Bidirectional communication between gut and liver mediated by gut microbiota and their metabolites
- Bile acid imbalance affecting metabolic signaling 2
- Gut microbiota-derived metabolites directly influencing hepatic inflammation and metabolism 2, 5
- Adipose-liver axis communication through inflammatory mediators and extracellular vesicles 2
Progression Factors
The strongest determinants of disease progression to cirrhosis and HCC are obesity (particularly central obesity) and type 2 diabetes 6. Additional risk amplifiers include:
- Male sex aged >50 years and postmenopausal status 6
- Multiple concurrent cardiometabolic risk factors 6
- Fibrosis stage is the strongest predictor of liver-related mortality and HCC risk 6
Integrated Pathological Network
The pathogenesis reflects a multifactorial systemic disease rather than isolated hepatic pathology 2, 3:
- Extracellular vesicles (EVs) serve as mediators of metabolic and inflammatory signaling between organs 2
- The disease involves complex interactions among all the above mechanisms, creating self-perpetuating cycles of metabolic dysfunction
- Progressive fibrogenesis occurs through sustained inflammatory activation and hepatic stellate cell activation 3
Critical clinical implication: MAFLD is not merely a liver disease but a hepatic manifestation of systemic metabolic dysfunction, explaining why it substantially increases risk of cardiovascular disease, chronic kidney disease, and extrahepatic malignancies beyond liver-related outcomes 6, 3.